Headshop.com Sleep Collection Review 2026: THC Gummies Sold as Sleep Aids, Three Months From a Federal Cap
Headshop.com's sleep range is not melatonin and valerian—it is hemp-derived Δ9 THC and CBN. The lab reports are published, which is genuinely good. What isn't disclosed is that THC's sleep benefit fades with nightly use, that stopping makes sleep worse before it gets better, and that a federal cap taking effect on November 12, 2026 makes this entire collection non-compliant.
By Med Consumer Watch Team
Headshop.com's Sleep collection is eleven products priced from **$2.68 to $74.99**. If you arrived expecting melatonin, magnesium and valerian, that is not what this is. Nine of the eleven are **hemp-derived cannabinoid products**, and several contain **5 mg of Δ9 THC per gummy** alongside CBN and CBD. Headshop.com is an established online retailer founded in 2002, based in Encinitas, California. We pulled the full collection and read the product copy on July 30, 2026.
This review contains affiliate links, and we earn a commission if you buy through them. The assessment is our own. It is informational only and not medical advice.
Three things shape this review, and only one of them is a criticism of the seller.
**They publish lab reports.** Certificates of analysis, with specific lot numbers, linked per product. In the hemp category that is a real credit and a lot of sellers do not do it.
**THC's relationship with sleep is more complicated than any of this copy admits** — it works at first, then stops working, and stopping makes things worse before they get better.
**And on November 12, 2026 — about fifteen weeks from now — a federal cap takes effect that this entire collection exceeds.**
What's Actually in the Collection
Doses below are as stated by Headshop.com in its own product descriptions.
"Contains less than 0.3% THC" appears across this collection and it is one of the most misunderstood phrases in the hemp market. It is a percentage by dry weight, not a dose. A gummy can be well under 0.3% THC by weight and still contain 5 mg of Δ9 THC — which is a real psychoactive dose for most people, and roughly half a standard dispensary edible. The percentage describes the legal status of the plant material. It tells you nothing about how much THC you are about to swallow. Read the milligrams.
The Federal Deadline This Collection Runs Into
This is the single most important thing for anyone buying hemp THC products right now, and it is not specific to Headshop.com — it applies to the entire category.
Congress passed a new federal definition of hemp on **November 12, 2025**, signed into law as **Section 781 of the Continuing Appropriations and Extensions Act, 2026 (P.L. 119-37)**, with a one-year delayed implementation. It takes effect on **November 12, 2026**.
Two changes matter:
**The definition shifts to total THC.** The 0.3% threshold becomes 0.3% *total* THC on a dry weight basis, inclusive of THCA and delta-8 — closing the conversion loophole most of this market is built on.
**And finished products get a hard per-container cap: 0.4 mg of total THC per container.**
Run that against this collection. A single Gold Naturals 5 mg Δ9 gummy contains **12.5 times the entire per-container allowance**. A 30-count bag of them would be roughly 150 mg of THC — about **375 times** the cap.
There have been sustained legislative efforts to delay or repeal Section 781. As of the most recent reporting we could find, **none has passed committee, and none has been enacted**. Unless that changes, the November 12, 2026 date stands.
If you buy these products, do not build a routine around them assuming continuity of supply. In roughly fifteen weeks the federal framework that makes them lawful is scheduled to change, and a 5 mg Δ9 gummy is not close to the new limit — it is more than an order of magnitude over it. State laws vary and enforcement timelines are uncertain, but a nightly sleep aid that may become unavailable at short notice is a poor foundation for a sleep routine, particularly given the rebound effects described below.
This is a reason to be sceptical of bulk-buying offers in this category between now and November. "Stock up before the deadline" is currently a common marketing angle across hemp retail, and it asks you to spend money now on a product whose legal status is about to change and whose effectiveness declines with continuous nightly use.
What THC Actually Does to Sleep
This is the part no product page in this collection explains, and it is the part that determines whether these products will still be working for you in three months.
**THC does help you fall asleep, at first.** It reliably shortens sleep onset latency, and it increases time in stage N3 — deep, physically restorative slow-wave sleep. That is a genuine effect and it is why these products feel like they work on night one.
**It suppresses REM sleep.** REM is where dream-based emotional processing and a good deal of memory consolidation happen. Long-term REM suppression has been associated with effects on memory consolidation, emotional regulation and mood. At low doses — around 2.5 mg — this appears minimal. At 10 mg and above, nightly use progressively suppresses REM. **The 5 mg gummies in this collection sit between those two points**, and two of them is 10 mg.
**Tolerance develops.** This is the most consistent complaint in the literature and the most predictable trajectory for a nightly user: it works well, then gradually less well. Half a gummy becomes one, one becomes two, and the sleep benefit plateaus while consumption climbs.
**And stopping is worse than not starting.** REM rebound is one of the most consistent findings in the cannabis withdrawal literature — a period of intensified, vivid dreaming that disrupts sleep, alongside rebound insomnia. The timeline is predictable: symptoms typically begin 24 to 48 hours after the last dose and peak between days two and six.
Put those together and you get the shape of the problem. A nightly THC sleep product tends to become a product you need in order to sleep as well as you did before you started it. That is not a reason nobody should ever use one. It is a reason to use it occasionally rather than nightly, and to know what you are signing up for — which is information the buyer is not being given here.
If you want to use one of these, the harm-reduction version is straightforward: use it for short stretches rather than continuously, keep the dose low — half a 5 mg gummy is a reasonable starting point — and take regular breaks before tolerance sets in rather than after. If you already need it nightly to sleep, that is worth raising with a doctor, because the underlying insomnia has not been treated.
CBN: The "Sleep Cannabinoid" With Surprisingly Thin Evidence
CBN is the ingredient this collection is built on — 20 mg in the Entourage sleep gummy, and a $74.99 tincture at 100 mg per mL. It is marketed across the industry as the sleep cannabinoid. The evidence is weaker than that reputation.
Until recently there were essentially no well-designed trials. As one 2023 protocol paper put it, despite anecdotal and preclinical interest, the effects of CBN isolate on sleep had never been examined through proper clinical trial procedures.
Two trials have since reported. One found that **20 mg of CBN** improved sleep disturbance including nighttime awakenings — a positive signal at a dose that matches what is in the Entourage gummy.
The other is the more informative one, and it complicates the story. A randomised, double-blind, placebo-controlled trial tested **three CBN doses — 25 mg, 50 mg and 100 mg — against placebo and against melatonin**. All three CBN groups improved significantly versus placebo. But there were **no significant differences between any of them**, and **no significant difference between any CBN group and the melatonin group**.
Two conclusions follow. First, no dose-response across a fourfold dose range is a strong hint that the effect is not specific to the amount of CBN — which is exactly what you would not expect if CBN were doing the work pharmacologically. Second, and more practically: **CBN performed no better than melatonin**, and melatonin costs a fraction of $74.99.
That is not a claim that CBN does nothing. It is a claim that the premium is not currently justified by the evidence.
Two Products That Need Specific Notes
**URB Landing Skybites ($24.99)** stacks CBD, CBN, Δ9 THC, sedative terpenes and **melatonin** in one gummy. Two things follow. Combining THC and melatonin is a real sedative stack, and if you also take a prescription sedative, an antihistamine or alcohol, the additive effect is worth taking seriously. And melatonin itself has a documented labelling problem: a 2023 *JAMA* analysis of melatonin gummy products found **22 of 25 were inaccurately labelled**, with actual content ranging from 74% to 347% of what the label claimed. When melatonin is a minor listed ingredient inside a multi-cannabinoid gummy, the odds of the stated amount being the real amount are not better than that.
**Slightly Elevated Mushroom & Cannabinoid Blend Gummies ($50.00)** is the one product in the collection we cannot assess, because the listing does not say what is in it. The description refers to "high-quality mushrooms" and "a powerful blend of mushrooms known for their adaptogenic" properties, with no species named and no amounts given, alongside unspecified cannabinoids. At $50 for 30 gummies, that is a lot of money for an ingredient list you cannot read.
We are not suggesting anything untoward is in it — we have no evidence either way, and that is precisely the issue. "Mushroom" in the current market covers everything from reishi and lion's mane, which are ordinary functional mushrooms, to *Amanita muscaria*, which contains muscimol and ibotenic acid and is genuinely psychoactive. Those are wildly different products and a buyer is entitled to know which one they are holding.
Before buying any mushroom-and-cannabinoid product, find the species names and the milligram amounts on the label or the certificate of analysis. If a $50 product will not tell you what mushroom is in it, that is your answer. And keep any THC or Amanita-containing edible locked away from children — paediatric edible cannabis exposures reported to US poison centres rose from around 200 in 2017 to 3,054 in 2021, with 22.7% of those children hospitalised and 8% requiring critical care.
What Headshop.com Gets Right
**They publish certificates of analysis, per lot.** This is the credit that matters most in this category. The Sleep Tincture listing goes as far as naming individual lot numbers — 2106094A, 2106093A, 2106082A — each with its own linked CoA for the light, medium and heavy strengths. Several other products link lab reports directly. Hemp is an unregulated market where potency and contaminant testing is the only real quality control available, and a retailer that publishes lot-specific results is doing the right thing.
**Doses are disclosed in milligrams.** "5 mg of Δ9 THC, 20 mg of CBN, and 40 mg of CBD" is exactly how this should be written. Many competitors hide behind "full spectrum blend."
**They flag state compliance.** Several products are labelled "Utah Compliant," which acknowledges that hemp rules vary by state and that a product legal in one may not be legal in another. That is more care than the category norm.
**The retailer is established and identifiable.** Founded in 2002, based in Encinitas, California, with named leadership and a 30-day return policy.
**The known weaknesses are operational.** Independent customer reviews cluster on shipping and fulfilment: orders arriving late, partial shipments, wrong items, and — in at least one reported case — a refusal to provide a prepaid return label for faulty merchandise, leaving the customer to pay return postage. Refunds do appear to be issued when pursued. These are ordinary e-commerce complaints rather than product-safety ones, but if you are ordering something time-sensitive, factor them in.
Who This Is For, and Who It Isn't
**This collection might suit you if:** you already use hemp THC products, you understand what 5 mg of Δ9 does to you specifically, and you want occasional rather than nightly help with sleep onset; you value published lot-specific lab reports; and you live in a state where these products are lawful and you accept that the federal position changes in November.
**Look elsewhere if:** you are new to THC — a 5 mg Δ9 edible is a meaningful dose and a sleep aisle is a strange place to encounter your first one; you want something you can take every night indefinitely, because tolerance and REM rebound make that a poor plan; you are pregnant or breastfeeding; you take a prescription sedative, an opioid, or drink in the evening, all of which stack with this; you are subject to workplace drug testing, because 5 mg Δ9 gummies will produce a positive result regardless of their legal status; or you want CBN specifically and would rather not pay a premium over melatonin for it.
**And if the problem is chronic insomnia rather than the occasional bad night:** the treatment with the strongest evidence is **CBT-I** — cognitive behavioural therapy for insomnia — which outperforms sedatives in the long term and does not build tolerance. It is available through apps and via primary care referral. Persistent insomnia is also a common presentation of sleep apnoea, thyroid disease, depression and restless legs, none of which a gummy addresses.
Frequently Asked Questions
**Are these products legal?**
As of July 30, 2026, hemp-derived Δ9 THC products under 0.3% THC by dry weight are federally lawful, though state law varies considerably. That changes on **November 12, 2026**, when Section 781 shifts the definition to total THC and caps finished products at 0.4 mg total THC per container. A 5 mg Δ9 gummy is 12.5 times that cap. Efforts to delay Section 781 have not passed as of the latest reporting we could find.
**Will a 5 mg Δ9 gummy get me high?**
For most people, yes, to some degree — it is roughly half a standard dispensary edible dose. "Contains less than 0.3% THC" describes weight percentage, not dose, and does not mean non-psychoactive.
**Will these show up on a drug test?**
Yes. Δ9 THC is Δ9 THC regardless of whether it came from hemp or cannabis, and standard workplace panels test for THC metabolites. Even CBD-dominant full-spectrum products can produce positives.
**Does CBN actually work for sleep?**
The evidence is thin. One trial found 20 mg improved sleep disturbance. A larger randomised trial testing 25, 50 and 100 mg found all doses improved sleep versus placebo but showed no differences between doses and **no difference from melatonin**. No dose-response across a fourfold range suggests the effect may not be CBN-specific.
**Is THC good for sleep long term?**
It shortens sleep onset and increases deep sleep initially, but it suppresses REM, tolerance develops with nightly use, and stopping causes REM rebound and rebound insomnia peaking around days two to six. It is better suited to occasional use than to a nightly routine.
**Are these products lab tested?**
Yes, and this is Headshop.com's strongest point. Certificates of analysis are published, and several products list specific lot numbers with a CoA for each.
**What's in the mushroom gummies?**
The listing does not say — no species, no amounts. At $50 for 30 gummies we would want that answered before buying.
**What are the shipping and returns like?**
A 30-day return policy is offered. Independent reviews report recurring issues with shipping delays, partial orders and wrong items, and at least one case of the company declining to supply a prepaid return label for faulty goods.
The Bottom Line
**Our rating: 4.6 / 10.**
Headshop.com does the one thing that matters most in an unregulated category: it publishes lab reports, down to individual lot numbers, and it states cannabinoid doses in milligrams rather than hiding behind "full spectrum." Those are real credits and we would rather buy hemp from a retailer that does this than one that does not.
The score reflects what surrounds them. This is a sleep aisle in which nine of eleven products are cannabinoid preparations and several contain 5 mg of Δ9 THC — a genuinely psychoactive dose, sold under the phrase "contains less than 0.3% THC," which describes weight and not dose and which we think misleads more buyers in this market than any other single sentence. Nothing on these pages explains that THC suppresses REM sleep, that tolerance builds with nightly use, or that stopping produces rebound insomnia and vivid dreams peaking around days two to six — which is the trajectory a nightly user is actually buying. The CBN the collection is built around performed no better than melatonin in the best trial available and showed no dose-response across a fourfold range, which makes a $74.99 tincture hard to justify. And a $50 mushroom gummy will not tell you what mushroom is in it.
Then there is the calendar. On **November 12, 2026**, roughly fifteen weeks from now, the federal cap of 0.4 mg total THC per container takes effect, and a single 5 mg gummy exceeds it more than twelvefold. No delay has been enacted. Whatever you think of that law, it is a poor moment to build a nightly sleep routine on this category, and a worse one to stock up.
If you want occasional help falling asleep and you already know how 5 mg of Δ9 affects you, the Gold Naturals gummies are transparently dosed and lab-tested, which is more than most. If you want to fix your sleep, the answer is CBT-I, and it is free of all of the above.
Headshop.com — Sleep collection product feed: 11 products, stated cannabinoid doses, lot numbers and linked certificates of analysis (checked July 30, 2026)
Section 781, Continuing Appropriations and Extensions Act, 2026 (P.L. 119-37) — signed November 12, 2025 with one-year delay; total-THC definition inclusive of THCA and delta-8; finished products capped at 0.4 mg total THC per container from November 12, 2026
Published evidence on cannabis and sleep architecture: reduced sleep onset latency, increased stage N3, REM suppression, tolerance with chronic use, and REM rebound and rebound insomnia on discontinuation peaking days two to six
Cohen PA, et al. — JAMA 2023 analysis of melatonin gummy products: 22 of 25 inaccurately labelled, 74%–347% of declared content
American Academy of Pediatrics, Pediatrics — paediatric edible cannabis exposures reported to US poison centres rose from approximately 200 (2017) to 3,054 (2021); 22.7% hospitalised, 8% critical care
American College of Physicians — cognitive behavioural therapy for insomnia (CBT-I) recommended as first-line treatment for chronic insomnia disorder
Medical Disclaimer
This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making decisions about your health or medications. Individual experiences may vary.